Doctors described it as "ingenious" and were impressed by its effectiveness. They also highlighted the importance of its availability to patients through Apotek1, emphasizing the added convenience and accessibility for those in need of a reliable solution for managing nosebleeds. The positive feedback from healthcare providers reinforces the product's value in the clinical setting.
Positive Reception for NosePlug at ENT Exhibition in Oslo, 24-26 October
At an ENT exhibition in Oslo, medical professionals expressed high praise for the NosePlug, a product designed to treat epistaxis (nosebleeds).

Similar Posts

Dr. Peter Åhnblad will be featured as a keynote speaker at 15th Annual PODD in Boston, USA
Hogne is proud to share that Dr. Peter Åhnblad will be featured as a keynote speaker at 15th Annual PODD, Partnership Opportunities in Drug Delivery, one of the leading global forums for Drug Delivery taking place in Boston October 27-28, 2025.. The keynote, “TrigeNas™ - Innovative nasal delivery platform for direct and efficient dug administration,” will outline new perspectives on Physical and Formulation Approaches for Brain Delivery.
Hogne presents the NosePlug® at Sweden's most significant ear, nose and throat scientific congress 2025
The ENT Days is Sweden's most significant scientific congress on ear, nose, and throat diseases, as well as head and neck surgery. This year's event took place from September 10-12 in Uppsala and featured a top-tier scientific program.

Hogne Showcasing the Noseplug at Drug Delivery Summit 2024
Hogne is thrilled to announce its participation in the Drug Delivery Summit 2024, taking place in San Diego, California, USA, on February 3–4, 2025.